Prosper Junior Bakiny, The Motley Fool November 8, 2025 at 10:30 AM Key Points Eli Lilly delivered fantastic third-quarter results, largely thanks to tirzepatide.
Latest News
When anxiety stirs your stomach: How the brain-gut connection affects digestion (and what you can do)
Image generated using an AI tool Ever feel your stomach tighten when you’re anxious? That’s no coincidence — your gut and brain constantly talk
Should You Buy Oklo Stock While It's Under $171?
Oklo shares have pulled back since setting all-time highs in October. Oklo (OKLO +5.53%) went public in 2024 by merging with a special purpose
From Jamie Dimon to Bill Ackman, Wall Street’s billionaires are now changing their tune and offering to help Zohran Mamdani
Zohran Mamdani, who ran his campaign on tackling the cost of living through policies like city-run groceries, free public transit, and universal childcare, was
This Stock Is Up Over 90% in 2025 — And You May Have Never Heard of It
Steven Porrello, The Motley Fool November 8, 2025 at 9:45 AM Key Points Nano Nuclear Energy is developing microreactors that could supply reliable power.
Can a One-Time Gene Therapy Lower Cholesterol?
Lowering cholesterol is one of the most effective ways to reduce your risk of heart disease, and it may soon be possible to get
CRISPR gene-editing works to reduce high cholesterol in a new study
Patients with high cholesterol often take medicine for years to manage it but a new gene-editing treatment has potential to make a difference. TEK
Stock market outlook 2026: JPMorgan says retail investors will drive next big rally – here’s what you need to know
US stock market prediction 2026: Retail investors are showing no signs of slowing down, and JPMorgan Chase believes their momentum could carry well into
Here’s the exact amount of carbs you should eat per day to lose weight, according to a dietitian
If you’ve ever tried to lose weight, you’ve probably heard someone say that cutting carbs is the key. No bread, no pasta, no potatoes.
Nvidia Stock’s Path to $350. Could Such a Rally Pressure Burry to Close His Bet?
Dr. Michael Burry, a man of “The Big Short” fame, has a lot of courage to bet against a high-flying company like Nvidia (NASDAQ:NVDA),